Page last updated: 2024-08-18

cyclohexanol and Tobacco Use Disorder

cyclohexanol has been researched along with Tobacco Use Disorder in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damaj, MI; Ignatowska-Jankowska, BM; Lichtman, AH; Muldoon, PP1
Cinciripini, L; Cinciripini, P; De Moor, C; Minna, J; Tomlinson, G; Tsoh, J; Wetter, D1
Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW1
Chen, MC; Lane, HY; Lin, CH; Lin, CY; Lin, KS1

Trials

2 trial(s) available for cyclohexanol and Tobacco Use Disorder

ArticleYear
The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2004, Volume: 6, Issue:2

    Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Double-Blind Method; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride

2004
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
    Experimental and clinical psychopharmacology, 2005, Volume: 13, Issue:4

    Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride

2005

Other Studies

2 other study(ies) available for cyclohexanol and Tobacco Use Disorder

ArticleYear
The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.
    Psychopharmacology, 2013, Volume: 229, Issue:4

    Topics: Animals; Anisoles; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclohexanols; Dose-Response Relationship, Drug; Female; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Receptor, Cannabinoid, CB2; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder

2013
Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
    The Journal of clinical psychiatry, 2008, Volume: 69, Issue:1

    Topics: Adult; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Interview, Psychological; Male; Mood Disorders; Patient Readmission; Prevalence; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Venlafaxine Hydrochloride

2008